Randhawa Simrat's Form 4 filing
Dianthus Therapeutics, Inc. (DNTH) · filed Mar 13, 2026
- Accession no.
- 0001992260-26-000004
- Filed
- Mar 13, 2026
- Trade date
- Mar 12, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 4 derivative transactions. Open-market sales total $2.76M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Randhawa SimratCIK 0001992260 | Officer (EVP, Head of R&D) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock | MOption exerciseAcquired | +7,998 | $8.44 | +$67,503.12 | 7,998 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseAcquired | +5,000 | $17.88 | +$89,400 | 12,998 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseAcquired | +8,332 | $21.77 | +$181,387.64 | 21,330 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseAcquired | +12,500 | $22.07 | +$275,875 | 33,830 | Direct | |
| Mar 12, 2026 | Common Stock | SSaleDisposed | −33,830 | $81.48 | −$2,756,468.4 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Common Stock | MOption exerciseDisposed | −7,998 | $0.00 | $0 | 3,998 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 71,184 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseDisposed | −8,332 | $0.00 | $0 | 54,174 | Direct | |
| Mar 12, 2026 | Common Stock | MOption exerciseDisposed | −12,500 | $0.00 | $0 | 106,250 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.